Empower Clinics Inc. announced that its subsidiary EPW Curesearch LLC (EPWC) has signed new agreements for additional pharmaceutical research and clinical trials medical doctors with an established pain management practice and includes two experienced principal investigators. In addition, the company announces EPWC sites and principal investigators (PI's) are officially in application stage for multiple study protocols for diseases that include Alzheimer's, Autoimmune Disorders, Chronic Obstructive Pulmonary Disease (COPD), Rheumatoid Arthritis (RA), Lupus and Diabetes, as the current priorities. The initial medical site with four (4) PI's has identified in excess of 1,100 patients from their existing patient roster that may meet the eligibility criteria for the nine (9) current applications under review.

PI's are practicing medical doctors who are specialists or internists with previous research and clinical trials experience. As such, they are integral to the success of any Site Management Organization (SMO) as follows: SMO leverages the medical practice of the PI's and their patient rosters to generate new participants in active clinical trials and research, which in turn commences meaningful revenues from the Biotech and Pharmaceutical industries. SMO will provide oversight, direction and support to the PI's and their patients.

SMO will also act as a liaison between the pharmaceutical company and the assigned Contract Research Organization (CRO). Target trials typically span one to two years in length and can be extended if the trial has not yet gathered enough data or has not been closed.